Pasithea Therapeutics Corp KTTA Q1 2026 Earnings Significant EPS Beat Despite Zero Revenue BIOA Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage BNAI Q3 2025 Earnings NarrowerThanExpected Loss Drives Positive Surprise Despite Revenue Absence AMTD IDEA Group Q4 2020 Earnings Strong EPS Beat Amid Revenue Disclosure Gap Editas Medicine Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment NAII Q2 2024 Earnings Loss Per Share of 052 Highlights Challenges